Hsa erectililty is not ‘normal’ in women, study finds
A new study has found that women with HSA erectile disorder have a significantly lower likelihood of developing dementia and heart disease.
Hsa is an autoimmune disease that causes the body’s immune system to attack its own cells.
The research, led by researchers from University of Cambridge, found that men with Hsa had significantly higher levels of TNF-α, a cytokine that can damage the heart and cause it to fail.
They also found that people with Hs were significantly less likely to die from heart disease, stroke or diabetes.
“In fact, in the UK, only one in 10 men and one in nine women has Hsa, while in Germany it is one in five and one out of five, respectively,” Dr Michael Kuehnert from the University of California, San Francisco, and his team wrote in their study.
“For the first time we have been able to identify a genetic basis for Hsa’s pathophysiology and to predict the impact of a gene on Hsa-associated conditions.”‘
A genetic difference’The team said their findings are the first to show a genetic difference between men and women with chronic Hsa and that this difference could affect the risk of dementia and cardiac disease.
“Our results suggest that men and woman with chronic HSAs are not genetically identical but may be different in a number of key aspects,” the researchers wrote in the study, published in the journal Archives of Internal Medicine.
“In particular, Hsa may be associated with a significantly higher prevalence of the autoimmune disease and other diseases that contribute to heart disease and dementia, such as diabetes.”‘
There is no reason to believe Hsa causes dementia’Dr Kuehneert added that “the findings do not mean that Hsa itself is the cause of heart disease or diabetes, but rather that Hs are associated with these diseases”.
“This means that HSA is not a ‘genetic disease’ in itself, but instead may be a genetic marker that can be useful in detecting an increased risk of certain diseases,” he told The Independent.
“This is an important finding as it could lead to new treatments for Hs in the future.”‘
This is not the end of the story’The researchers said that their findings do “not imply that Hsg is a causal cause of any of the conditions that are associated to Hsa”.
“Hs does not cause the majority of diseases, but we still need to investigate further the genetic and epigenetic mechanisms underlying Hsa.”
The findings do indicate that Hsb is not caused by Hsa alone and that other genetic markers are associated and should be investigated in more detail,” they added.
‘It’s just a few hundred thousand people’Hsa is currently a relatively new condition in the US.
It is estimated that it affects one in 100 people and affects up to three billion people around the world.
Although Hsa was first recognised in the 1980s, it is still difficult to diagnose because the disease is not always diagnosed at birth, which means it is not diagnosed by the doctor.
Dr Kuela Schatz, a researcher at the University College London’s Institute of Neuroscience and Psychology, said: “It’s not surprising that Hss is a new disease and people don’t think it’s caused by HSAs.”
There’s just not a lot of research into the genetic underpinnings of Hsa.”
Dr Schatz added that it was “a little difficult” to determine the genetic makeup of Hs.
“It’s been difficult to find an epidemiological database that does not contain some people with HSAs,” she said.
“We can’t say whether the presence of HSA affects our own mental health, or whether it’s the result of a genetic predisposition or just a random mutation.”
Dr Kuhnert said there was still a lot to learn about Hs, particularly the genetic basis of the condition.
“I think the next step is to get a better understanding of the molecular and genetic basis, so that we can develop more targeted interventions that could be able to protect people from Hs,” he said.
This article first appeared on The Independent here